查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1951327

毛細管電泳市場 - 全球產業規模、佔有率、趨勢、機會及預測（按組件、模式、應用、最終用戶、地區和競爭格局分類），2021-2031年

Capillary Electrophoresis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component, By Mode, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球毛細管電泳市場預計將從 2025 年的 4.0805 億美元成長到 2031 年的 5.7621 億美元，複合年成長率達到 5.92%。

此分析技術利用亞毫米級毛細管內的電壓，根據離子的電泳遷移率分離離子。市場成長的主要驅動力是慢性病發病率的上升以及由此帶來的個人化醫療需求，而個人化醫療需要精準的診斷工具來識別生物標記。此外，蓬勃發展的生物製藥產業也越來越依賴這項技術，在生產過程中對單株抗體進行詳細的表徵和品管。這些根本性的促進因素不同於小型化和與質譜聯用等技術變革，因為它們反映的是推動技術應用的基本操作需求，而非方法本身的演進。

市場概覽
預測期 2027-2031
市場規模：2025年 4.0805億美元
市場規模：2031年 5.7621億美元
複合年成長率：2026-2031年 5.92%
成長最快的細分市場 測量設備
最大的市場 北美洲

儘管市場呈現上升趨勢，但由於缺乏熟練操作這些先進系統並能分析其所產生複雜數據的合格專業人員，市場仍面臨許多挑戰。這種專業技能的缺口會限制實驗室的吞吐量，並減緩先進技術的應用。為了展現支撐這些技術的產業規模，主要產業協會的數據提供了有關生產產出的洞見。根據日本分析儀器製造商協會統計，2024年毛細管電泳所需的分離分析儀的產值將達到約648億日圓。

市場促進因素

製藥和生技領域研發投入的不斷成長是推動全球毛細管電泳市場發展的主要因素。隨著產業朝向複雜生物製藥（包括基因療法和單株抗體）方向發展，對高解析度分析方法的需求日益成長，以檢驗藥物的穩定性和純度。毛細管電泳已成為表徵這些高階研發階段的聚醣和電荷異質性的關鍵技術，促使企業對相關設備進行大量投資。主要產業參與者的巨額研發投入凸顯了這種研發強度。強生公司報告稱，截至2025年1月，其2024會計年度的研發支出為172億美元，這證實了企業在採用先進工具進行藥物研發方面投入了大量資金。

此外，技術進步，特別是微晶片毛細管電泳技術的興起，突破了傳統技術在靈敏度和通量方面的限制，加速了市場擴張。這些創新實現了快速分離和與質譜的有效整合，為現代蛋白質體學和基因組學研究提供了至關重要的能力。這些微型化裝置的效率提升使得生物標記的偵測更加精準。例如，2025年1月發表於《色譜雜誌A》（Journal of Chromatography A）的一篇題為「微晶片毛細管電泳-質譜聯用技術用於高通量同時分析B族維生素」的論文詳細介紹了一種新的微晶片方法，該方法實現了低於4 ppb的檢測極限和低於3分鐘的分離時間。作為支撐這些進步的廣泛產業環境的例證，Bio-Rad Laboratories在2025年報告稱，其生命科學部門2024年全年淨銷售額達到10.3億美元，凸顯了臨床和研究儀器市場的巨大規模。

市場挑戰

合格人員短缺是限制全球毛細管電泳市場成長的一大障礙。與更基礎的分析技術相比，毛細管電泳需要操作人員具備專門的技術技能，才能進行方法開發、選擇合適的緩衝液並解讀複雜的資料集。當實驗室缺乏具備此類專業知識的人員時，就會面臨操作瓶頸，導致樣本處理量下降，分析誤差增加。這種人力資源的匱乏直接阻礙了機構購買新設備，因為如果沒有合格的管理人員，儀器就無法發揮其全部潛力，從而有效地阻止了資本採購。

人才短缺的影響因全球範圍內大量技術系統的分佈而加劇，導致對專業人才的需求超過了目前的勞動力供應。隨著製造商將這些先進儀器出口到國際市場，對本地培訓的操作人員的需求也隨之增加。例如，日本分析儀器製造商協會的數據顯示，2024年分離和分析設備的出口額約為373億日元，凸顯了技術的全球流動。如此巨大的出口量表明，先進診斷工具的供應與能夠操作這些工具的合格人員數量之間存在脫節，這從根本上限制了市場的實際成長潛力。

市場趨勢

與傳統的蛋白質表徵不同，毛細管電泳市場在基因治療領域實現了向病毒載體和質體DNA分析的多元化發展，這標誌著該領域的重大變革。隨著生物製藥產業加速開發細胞和基因療法，其越來越依賴毛細管電泳技術來精確分離超螺旋質體DNA和線性異構體，並確定病毒衣殼的包裝狀態。這項應用對於檢驗複雜基因藥物的有效性和安全性至關重要，並且需要先進的分析基礎設施。支援這些工作流程的儀器投資巨大。根據賽默飛世爾科技公司於2025年1月發布的「2024年第四季及全年業績」新聞稿，該公司分析儀器部門（為這些治療方法的研發提供支援）僅在2024年第四季就累計了21.9億美元的收入。

同時，市場趨勢正推動毛細管電泳工作流程朝向全自動、高通量方向顯著轉變，以提高實驗室的重複性和效率。研究實驗室正逐漸從手動凝膠技術和單毛細管系統轉向並行處理平台，這些平台能夠以最少的操作人員干預同時分析大量樣品。這種轉變的驅動力在於最佳化品管程式並快速產生用於大規模篩檢的數位資料，從而減少人為錯誤和操作延遲。主要儀器供應商的財務表現也印證了對這類自動化解決方案的強勁需求。島津公司於2025年2月宣布，其分析測量儀器業務截至2024年12月31日的九個月淨銷售額約為2,479億日元，凸顯了該產業對先進、高效分離技術的持續依賴。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球毛細管電泳市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按組件（儀器、耗材、軟體）
    • 透過方法（毛細管區帶電泳、毛細管層析法等）
    • 透過應用（核酸分析和蛋白質分析）
    • 依最終用戶（生技/製藥公司、臨床檢查室、學術/研究機構、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美毛細管電泳市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲毛細管電泳市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區毛細管電泳市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲毛細管電泳市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲毛細管電泳市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球毛細管電泳市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc
  • Merck KGaA
  • Promega Corporation
  • Shimadzu Corporation
  • LABGENE Scientific SA

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 12992

The Global Capillary Electrophoresis Market is projected to expand from USD 408.05 Million in 2025 to USD 576.21 Million by 2031, achieving a compound annual growth rate of 5.92%. This analytical technique utilizes applied voltage within a submillimeter diameter capillary tube to separate ions based on their electrophoretic mobility. Market momentum is primarily generated by the increasing incidence of chronic diseases and the resulting need for personalized medicine, which requires accurate diagnostic tools for identifying biomarkers. Additionally, the growing biopharmaceutical sector depends heavily on this technology for detailed monoclonal antibody characterization and quality control during manufacturing. These foundational drivers are differentiated from technological shifts like miniaturization or mass spectrometry integration, as they reflect the fundamental operational necessities driving adoption rather than the evolution of the method itself.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 408.05 Million
Market Size 2031USD 576.21 Million
CAGR 2026-20315.92%
Fastest Growing SegmentInstruments
Largest MarketNorth America

Despite this upward trend, the market encounters a major obstacle due to a scarcity of qualified professionals skilled in operating these sophisticated systems and analyzing the complex data they yield. This expertise gap can restrict laboratory throughput and slow the uptake of advanced techniques. To demonstrate the industrial magnitude of the sector backing these technologies, data from leading trade associations offers perspective on manufacturing output. According to the Japan Analytical Instruments Manufacturers' Association, the production value of separation analysis apparatus, a category pivotal to capillary electrophoresis, reached approximately 64.8 billion JPY in 2024.

Market Driver

The increasing expenditure on research and development within the pharmaceutical and biotechnology sectors serves as a principal catalyst for the global capillary electrophoresis market. As the industry pivots toward complex biologics, including gene therapies and monoclonal antibodies, there is a heightened requirement for high-resolution analytical methods to verify drug stability and purity. Capillary electrophoresis has become essential for glycan analysis and characterizing charge heterogeneity during these advanced development stages, triggering substantial investment in required equipment. The scale of this research intensity is highlighted by the financial outlays of major industry participants; according to Johnson & Johnson, the company recorded $17.2 billion in research and development expenses for the full year 2024 in January 2025, underscoring the massive capital devoted to adopting sophisticated tools for drug discovery.

Furthermore, technological progress, specifically the rise of microchip-based capillary electrophoresis, is expediting market expansion by overcoming previous constraints regarding sensitivity and throughput. These innovations facilitate rapid separation times and effective integration with mass spectrometry, capabilities that are vital for contemporary proteomics and genomics research. The improved efficiency of these miniaturized units allows for more accurate biomarker detection. For instance, according to the Journal of Chromatography A in January 2025, an article titled 'Microchip capillary electrophoresis-mass spectrometry for high-throughput simultaneous analysis of B-complex vitamins' detailed a new microchip method that achieved detection limits below 4 ppb and separation times under three minutes. To demonstrate the wider industrial environment supporting these advancements, Bio-Rad Laboratories reported full-year 2024 net sales of $1.03 billion for its Life Science segment in 2025, emphasizing the substantial market size for clinical and research instrumentation.

Market Challenge

A scarcity of qualified personnel acts as a severe impediment to the growth of the Global Capillary Electrophoresis Market. In contrast to more basic analytical techniques, capillary electrophoresis demands operators who possess specialized technical skills to handle method development, select appropriate buffers, and interpret complex datasets. When laboratories are deficient in staff with this necessary expertise, they face operational obstructions that diminish sample throughput and heighten the probability of analytical inaccuracies. This gap in human resources directly discourages organizations from purchasing new instrumentation, as the equipment cannot be deployed to its full potential without capable supervision, effectively halting capital procurement.

The consequences of this workforce shortage are exacerbated by the large quantity of technical systems being distributed on a global scale, creating a need for expertise that exceeds the current labor supply. As manufacturers export these sophisticated instruments to international markets, the local requirement for trained operators escalates. Highlighting this global flow of technology, the Japan Analytical Instruments Manufacturers' Association reported that the export value of separation analysis apparatus stood at roughly 37.3 billion JPY in 2024. This substantial export volume underscores a growing disconnect between the provision of advanced diagnostic tools and the population of qualified experts available to run them, essentially constraining the market's practical growth potential.

Market Trends

The diversification into viral vector and plasmid DNA analysis for gene therapies marks a significant evolution in the capillary electrophoresis market, differing from standard protein characterization. As the biopharmaceutical industry hastens the development of cell and gene therapies, there is an increasing reliance on capillary electrophoresis to accurately separate supercoiled plasmid DNA from linear isoforms and distinguish between full and empty viral capsids. This application is crucial for validating the efficacy and safety of intricate genetic medicines, necessitating the installation of sophisticated analytical infrastructure. The magnitude of investment in the instrumentation underpinning these workflows is considerable; according to Thermo Fisher Scientific's January 2025 press release regarding Fourth Quarter and Full Year 2024 Results, their Analytical Instruments segment, which supports the creation of these therapies, generated $2.19 billion in revenue for the fourth quarter of 2024 alone.

Simultaneously, the market is experiencing a definitive transition toward fully automated, high-throughput capillary electrophoresis workflows to enhance laboratory reproducibility and efficiency. Laboratories are abandoning manual gel-based techniques and single-capillary systems in favor of parallel processing platforms capable of analyzing numerous samples concurrently with limited operator involvement. This shift is driven by the necessity to optimize quality control procedures and produce rapid, digital data for large-scale screening, thereby reducing human error and operational delays. The strong demand for such automated solutions is evident in the financial results of major equipment suppliers; according to Shimadzu Corporation in February 2025, the Analytical & Measuring Instruments segment reached net sales of approximately 247.9 billion JPY for the nine months ended December 31, 2024, emphasizing the sustained industrial dependence on advanced, high-efficiency separation technologies.

Key Market Players

  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc
  • Merck KGaA
  • Promega Corporation
  • Shimadzu Corporation
  • LABGENE Scientific SA

Report Scope

In this report, the Global Capillary Electrophoresis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Capillary Electrophoresis Market, By Component

  • Instruments
  • Consumables
  • Software

Capillary Electrophoresis Market, By Mode

  • Capillary Zone Electrophoresis
  • Capillary Electro Chromatography
  • Others

Capillary Electrophoresis Market, By Application

  • Nucleic Acid Analysis and Protein Analysis

Capillary Electrophoresis Market, By End User

  • Biotechnology & Pharmaceutical Companies
  • Clinical Laboratories
  • Academic & Research Institutions
  • Others

Capillary Electrophoresis Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Capillary Electrophoresis Market.

Available Customizations:

Global Capillary Electrophoresis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Capillary Electrophoresis Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Instruments, Consumables, Software)
    • 5.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 5.2.3. By Application (Nucleic Acid Analysis and Protein Analysis)
    • 5.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Capillary Electrophoresis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Mode
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Capillary Electrophoresis Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Mode
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Capillary Electrophoresis Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Mode
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Capillary Electrophoresis Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Mode
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Capillary Electrophoresis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Mode
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Capillary Electrophoresis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Mode
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. France Capillary Electrophoresis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Mode
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Capillary Electrophoresis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Mode
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Capillary Electrophoresis Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Mode
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Capillary Electrophoresis Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Mode
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia Pacific Capillary Electrophoresis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Mode
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Capillary Electrophoresis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Mode
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Capillary Electrophoresis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Mode
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Capillary Electrophoresis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Mode
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Capillary Electrophoresis Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Mode
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Capillary Electrophoresis Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Mode
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Middle East & Africa Capillary Electrophoresis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Mode
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Capillary Electrophoresis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Mode
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Capillary Electrophoresis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Mode
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Capillary Electrophoresis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Mode
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Capillary Electrophoresis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Mode
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Capillary Electrophoresis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Mode
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Capillary Electrophoresis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Mode
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Capillary Electrophoresis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Mode
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Capillary Electrophoresis Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. QIAGEN N.V.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific Inc.
  • 15.3. Agilent Technologies, Inc.
  • 15.4. Bio-Rad Laboratories, Inc.
  • 15.5. Danaher Corporation
  • 15.6. PerkinElmer, Inc
  • 15.7. Merck KGaA
  • 15.8. Promega Corporation
  • 15.9. Shimadzu Corporation
  • 15.10. LABGENE Scientific SA

16. Strategic Recommendations

17. About Us & Disclaimer